Top

Published in:

01-01-2021 | Hypertension | Clinical study

Hypertension with erenumab

Published in: Reactions Weekly | Issue 1/2021

Excerpt

There appears to be an association between hypertension and erenumab [Aimovig] treatment, according to the results of a case series reported in Headache, "with many cases requiring pharmacological intervention". …

Saely S, et al. Hypertension: A new safety risk for patients treated with erenumab. Headache : 10 Jan 2021. Available from: URL: http://doi.org/10.1111/head.14051

Title: Hypertension with erenumab
Publication date: 01-01-2021
Publisher: Springer International Publishing
Keywords: Hypertension
Triptan Drugs
Erenumab
Hypertension
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-89849-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Hypertension with erenumab

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Dimethyl fumarate: risk of PML associated with mild lymphopenia

Sulfasalazine

Levofloxacin

Digoxin/diltiazem/flecainide

Tenofovir-dipivoxil-fumarate

Low molecular weight heparins/warfarin